vs
Side-by-side financial comparison of American Express (AXP) and Stryker Corporation (SYK). Click either name above to swap in a different company.
American Express is the larger business by last-quarter revenue ($10.9B vs $7.2B, roughly 1.5× Stryker Corporation). American Express runs the higher net margin — 22.5% vs 11.8%, a 10.7% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs 9.9%). American Express produced more free cash flow last quarter ($2.3B vs $1.9B). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs 8.2%).
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...
The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).
AXP vs SYK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.9B | $7.2B |
| Net Profit | $2.5B | $849.0M |
| Gross Margin | — | 64.5% |
| Operating Margin | 28.2% | 25.2% |
| Net Margin | 22.5% | 11.8% |
| Revenue YoY | 9.9% | 11.4% |
| Net Profit YoY | 13.5% | 55.5% |
| EPS (diluted) | $3.52 | $2.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $10.9B | $7.2B | ||
| Q3 25 | $10.4B | $6.1B | ||
| Q2 25 | $10.3B | $6.0B | ||
| Q1 25 | $9.6B | $5.9B | ||
| Q4 24 | $10.0B | $6.4B | ||
| Q3 24 | $9.7B | $5.5B | ||
| Q2 24 | $9.8B | $5.4B | ||
| Q1 24 | $9.3B | $5.2B |
| Q4 25 | $2.5B | $849.0M | ||
| Q3 25 | $2.9B | $859.0M | ||
| Q2 25 | $2.9B | $884.0M | ||
| Q1 25 | $2.6B | $654.0M | ||
| Q4 24 | $2.2B | $546.0M | ||
| Q3 24 | $2.5B | $834.0M | ||
| Q2 24 | $3.0B | $825.0M | ||
| Q1 24 | $2.4B | $788.0M |
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 63.6% |
| Q4 25 | 28.2% | 25.2% | ||
| Q3 25 | 36.7% | 18.7% | ||
| Q2 25 | 34.4% | 18.5% | ||
| Q1 25 | 34.6% | 14.3% | ||
| Q4 24 | 27.7% | 9.0% | ||
| Q3 24 | 33.0% | 19.7% | ||
| Q2 24 | 38.6% | 19.4% | ||
| Q1 24 | 33.7% | 18.5% |
| Q4 25 | 22.5% | 11.8% | ||
| Q3 25 | 27.9% | 14.2% | ||
| Q2 25 | 28.0% | 14.7% | ||
| Q1 25 | 26.8% | 11.1% | ||
| Q4 24 | 21.8% | 8.5% | ||
| Q3 24 | 25.8% | 15.2% | ||
| Q2 24 | 30.7% | 15.2% | ||
| Q1 24 | 26.1% | 15.0% |
| Q4 25 | $3.52 | $2.20 | ||
| Q3 25 | $4.14 | $2.22 | ||
| Q2 25 | $4.08 | $2.29 | ||
| Q1 25 | $3.64 | $1.69 | ||
| Q4 24 | $3.04 | $1.41 | ||
| Q3 24 | $3.49 | $2.16 | ||
| Q2 24 | $4.15 | $2.14 | ||
| Q1 24 | $3.33 | $2.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $742.0M | $4.0B |
| Total DebtLower is stronger | $56.4B | — |
| Stockholders' EquityBook value | $33.5B | $22.4B |
| Total Assets | $300.1B | $47.8B |
| Debt / EquityLower = less leverage | 1.68× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $742.0M | $4.0B | ||
| Q3 25 | $1.3B | $3.3B | ||
| Q2 25 | $197.0M | $2.4B | ||
| Q1 25 | $261.0M | $2.3B | ||
| Q4 24 | $221.0M | $3.7B | ||
| Q3 24 | $120.0M | $3.9B | ||
| Q2 24 | $188.0M | $1.9B | ||
| Q1 24 | $69.0M | $2.3B |
| Q4 25 | $56.4B | — | ||
| Q3 25 | $57.8B | — | ||
| Q2 25 | $58.2B | — | ||
| Q1 25 | $51.2B | — | ||
| Q4 24 | $49.7B | — | ||
| Q3 24 | $53.5B | — | ||
| Q2 24 | $51.5B | — | ||
| Q1 24 | $48.8B | — |
| Q4 25 | $33.5B | $22.4B | ||
| Q3 25 | $32.4B | $21.8B | ||
| Q2 25 | $32.3B | $21.2B | ||
| Q1 25 | $31.2B | $20.9B | ||
| Q4 24 | $30.3B | $20.6B | ||
| Q3 24 | $29.7B | $20.1B | ||
| Q2 24 | $29.5B | $19.8B | ||
| Q1 24 | $28.8B | $19.2B |
| Q4 25 | $300.1B | $47.8B | ||
| Q3 25 | $297.6B | $47.1B | ||
| Q2 25 | $295.6B | $46.3B | ||
| Q1 25 | $282.2B | $46.0B | ||
| Q4 24 | $271.5B | $43.0B | ||
| Q3 24 | $271.0B | $43.8B | ||
| Q2 24 | $272.2B | $39.1B | ||
| Q1 24 | $269.3B | $39.4B |
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.78× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.80× | — | ||
| Q2 24 | 1.74× | — | ||
| Q1 24 | 1.70× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.1B | $2.1B |
| Free Cash FlowOCF − Capex | $2.3B | $1.9B |
| FCF MarginFCF / Revenue | 21.4% | 26.1% |
| Capex IntensityCapex / Revenue | 6.6% | 3.7% |
| Cash ConversionOCF / Net Profit | 1.25× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $16.0B | $4.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.1B | $2.1B | ||
| Q3 25 | $6.2B | $1.5B | ||
| Q2 25 | $4.4B | $1.1B | ||
| Q1 25 | $4.8B | $250.0M | ||
| Q4 24 | $5.8B | $1.9B | ||
| Q3 24 | $-1.8B | $1.5B | ||
| Q2 24 | $4.5B | $633.0M | ||
| Q1 24 | $5.6B | $204.0M |
| Q4 25 | $2.3B | $1.9B | ||
| Q3 25 | $5.6B | $1.4B | ||
| Q2 25 | $3.7B | $928.0M | ||
| Q1 25 | $4.3B | $127.0M | ||
| Q4 24 | $5.3B | $1.7B | ||
| Q3 24 | $-2.3B | $1.3B | ||
| Q2 24 | $4.0B | $481.0M | ||
| Q1 24 | $5.2B | $37.0M |
| Q4 25 | 21.4% | 26.1% | ||
| Q3 25 | 53.6% | 22.3% | ||
| Q2 25 | 36.3% | 15.4% | ||
| Q1 25 | 45.0% | 2.2% | ||
| Q4 24 | 53.1% | 25.9% | ||
| Q3 24 | -23.3% | 23.7% | ||
| Q2 24 | 40.4% | 8.9% | ||
| Q1 24 | 55.2% | 0.7% |
| Q4 25 | 6.6% | 3.7% | ||
| Q3 25 | 6.3% | 3.1% | ||
| Q2 25 | 6.0% | 3.0% | ||
| Q1 25 | 4.5% | 2.1% | ||
| Q4 24 | 5.0% | 4.1% | ||
| Q3 24 | 4.7% | 3.1% | ||
| Q2 24 | 5.8% | 2.8% | ||
| Q1 24 | 4.2% | 3.2% |
| Q4 25 | 1.25× | 2.52× | ||
| Q3 25 | 2.15× | 1.79× | ||
| Q2 25 | 1.51× | 1.26× | ||
| Q1 25 | 1.84× | 0.38× | ||
| Q4 24 | 2.66× | 3.54× | ||
| Q3 24 | -0.72× | 1.77× | ||
| Q2 24 | 1.50× | 0.77× | ||
| Q1 24 | 2.28× | 0.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXP
| US Consumer Services Segment | $4.2B | 38% |
| Commercial Services Segment | $3.1B | 28% |
| International Card Services Segment | $2.1B | 19% |
| Global Merchant And Network Services Segment | $1.7B | 15% |
| Financial Service Other | $471.0M | 4% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
